1 week Ago By ABMN Staff
NRI Wealth Management LC acquired a new stake in HCA Healthcare, Inc. ( NYSE:HCA – Free Report ) in the fourth quarter, Holdings Channel.com reports.
The fund acquired 9,648 shares of the company’s stock, valued at approximately $2,896,000. HCA Healthcare accounts for 2.0% of NRI Wealth Management LC’s holdings, making the stock its 10th largest holding.
A number of other institutional investors also recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc.
purchased a new stake in HCA Healthcare in the 2nd quarter valued at about $33,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $39,000. Canoe Financial LP purchased a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $41,000.
Capital Performance Advisors LLP purchased a new stake in HCA Healthcare in the third quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at $44,000. 62.
73% of the stock is owned by hedge funds and other institutional investors. Wall Street Analyst Weigh In HCA has been the subject of several research reports. JPMorgan Chase & Co.
reaffirmed a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. StockNews.
com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. TD Cowen cut their price objective on HCA Healthcare from $450.00 to $440.
00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price target for the stock from $400.00 to $320.
00 in a report on Monday, November 25th. Finally, Barclays lowered their price objective on HCA Healthcare from $396.00 to $392.
00 and set an “overweight” rating for the company in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.
com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.63. HCA Healthcare Stock Down 0.
8 % Shares of NYSE HCA opened at $297.75 on Friday. The company has a quick ratio of 1.
00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.
HCA Healthcare, Inc. has a 52-week low of $270.77 and a 52-week high of $417.
14. The business has a 50-day moving average price of $328.27 and a 200 day moving average price of $355.
06. The stock has a market cap of $75.42 billion, a PE ratio of 13.
37, a price-to-earnings-growth ratio of 1.21 and a beta of 1.63.
HCA Healthcare Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were paid a dividend of $0.66 per share.
This represents a $2.64 dividend on an annualized basis and a yield of 0.89%.
The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.
Insider Activity In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.
00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579.
This represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link .
Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.
00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700.
The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here .
Corporate insiders own 1.60% of the company’s stock. HCA Healthcare Profile ( Free Report ) HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States.
It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. Further Reading Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc.
( NYSE:HCA – Free Report ). Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter .
.
